Sundaram Multi Pap swings to ₹3.18 cr profit, but cash reserves are shrinking
The nano-cap reversed a ₹5.12 cr loss to post a FY26 profit of ₹3.18 cr. Revenue grew 7.6%, but cash and cash equivalents fell.
— 1 earlier story on Sundaram Multi Pap Ltd. →What's new
- Sundaram Multi Pap reported a net profit of ₹3.18 cr for FY26, a turnaround from a ₹5.12 cr loss in FY25.
- Revenue rose 7.6% to ₹137.11 cr. Q4 profit was ₹1.17 cr versus a prior loss of ₹0.85 cr.
- The cash flow statement shows a significant reduction in cash and cash equivalents.
Why this matters
For a company whose profit now represents ~4.8% of its entire market capitalization, the swing from a ₹5.12 cr loss to a ₹3.18 cr profit is operationally significant. The turnaround is offset by a sharp drop in cash holdings, raising questions about where the working capital is going even as profitability improves.
What we're watching
- The composition of the cash decline—is it working capital, capex, or a payout?
- Whether the profit growth is sustained in the coming quarters.
- Any management commentary on the cash flow reduction in the earnings release.
The full read
Sundaram Multi Pap is out of the red. The company posted a ₹3.18 cr net profit for FY26, a full reversal from the ₹5.12 cr loss it reported a year ago. Revenue climbed 7.6% to ₹137.11 cr, with the Q4 quarter itself contributing a ₹1.17 cr profit versus a ₹0.85 cr loss. For a nano-cap, the profit now represents about 4.8% of its market capitalization. The audit opinion is clean. But the fine print in the cash flow statement tells a different story: cash and cash equivalents fell significantly. That gap between paper profit and shrinking cash is the item to unpack. Profit is back. Where the cash went is the next question.
Questions answered
- How significant is the turnaround in absolute terms?
- The company moved from a net loss of ₹5.12 cr in FY25 to a net profit of ₹3.18 cr in FY26. This ₹8.3 cr swing is substantial for a nano-cap, with the profit representing ~4.8% of its market capitalization.
- Why is the cash flow reduction a concern?
- The rationale highlights a 'significant reduction in cash and cash equivalents' alongside the profit. This divergence suggests the profit may not be translating directly into cash, possibly due to inventory build-up, receivables, or other working capital needs.
- What was the growth in revenue?
- Revenue grew 7.6% year-on-year to ₹137.11 cr for FY26. The growth, combined with cost controls cited in the rationale, drove the bottom-line swing.
- Is the audit opinion clean?
- Yes, the rationale notes the company received an unmodified audit opinion, which adds credibility to the financial statements and the reported turnaround.
Story so far
All notes on SUNDARAM →- 25 May 2026 · 5:01 PM IST Sundaram Multi Pap swings to ₹3.18 cr profit, but cash reserves are shrinking
- 42d ago Sundaram approves FY26 results already disclosed. Nothing new.